Partner with enlightenbio to reach your target audience
Thank you for your interest in partnering with enlightenbio. Over the years we have created a uniquely, targeted audience rich in life science researchers, stakeholders, and decision-makers across the various sectors of academia, pharma, and the healthcare industry. Besides providing extensive consulting services within these sectors – learn more at About enlightenbio - which keeps us close to the pulse of new developments within the areas of genetics, genomics, and precision medicine, we provide monthly news updates, and publish information about exciting new companies and industry trends.
Underwriting the monthly newsletter provides a great opportunity to reach a highly targeted audience of life science researchers and key stakeholders in genomics, genetics, new technologies (e.g. CRISPR, blockchain, liquid biopsy), and clinical research across academia, pharma, as well as the commercial and the investment sector. Our monthly newsletter summarizes recent industry trends and news across the various disciplines that advance clinical applications, precision medicine, drug discovery and development, data analysis, and more.
Contact us to learn more about the various underwriting opportunities.
enlightenbio was founded in 2013 in the San Francisco Bay Area to provide a conduit between research and related technical and analytical resources. Our company consists of PhD level research scientists who bring decades of industry experience and expertise in the biotechnology, molecular diagnostics, pharma, and life science research markets. We are dedicated to communicating in the researcher’s language, identifying unmet needs, and understanding product development. Our goals are aligned with the needs of healthcare professionals and organizations to increase productivity and technology development and adaption, and to make sense of the resulting biological data.
In addition to the broad industry experiences of our staff - Applied Biosystems (now Thermo Fisher Scientific), DNAnexus, Iconix Biosciences, Incyte, Ingenuity Systems (now a Qiagen company), Roche, and Pfizer – we have built and maintained content curation services, defined product strategies, managed tactical product projects, performed extensive ecosystem analyses, and defined go-to-market plans.
Building on our initial project involvements, previous experiences and early successes - microarray and next-generation sequence data analysis, toxicogenomics, solutions for sequence data management, analysis, and interpretation, drug discovery, and biochemistry - we continuously monitor worldwide market trends in healthcare information technology, life sciences, genomics, clinical diagnostics, and medical devices space to expand our critical service offerings. Combined with our extensive global network, we can identify target market pain points and unmet needs, preform detailed market and product research, and undertake horizontal and vertical ecosystem or competitive analyses, and more.
This background with our future-focus makes us a resourceful and agile alternative to traditional market research companies. Our comprehensive knowledge of the market we live and breathe is invaluable to our partnerships and potential.